On 2 and 3 July local and international experts will discuss the impact of the human microbiome in health and disease development in Cosmocaixa.
In our bodies live 10 bacteria per human cell, a population that represents 10% of body weight of a person. They also have many more genetic resources: 600,000 genes against our 25,000 genes. The microbiome has a very significant weight in health and disease and experts in the field will discuss the latest developments in this area the next 2 and July 3 at CosmoCaixa.
This population of microorganisms are an important functional component and contribute to many processes in our body, such as the development of the central nervous system, immune system and digestion. But while many studies suggest that the dysfunction of the microbiome may also influence the development and clinical manifestations of many diseases such as obesity, inflammatory and circulatory system diseases, HIV infection, cancer or autism.
Microbiome modulation by probiotics, prebiotics and even microbiota transplantation is a challenge and an opportunity in the prevention and treatment of many diseases.
In the meeting, co-organized by B·Debate and the University of Vic - Central University of Catalonia (UVic-UCC), IrsiCaixa, the Vall d’Hebrón Research Institute (VHIR) and the Spanish National Cancer Research Centre (CNIO), there will be presented the most recent studies and theories, and it will be discussed about the future research lines in this ambit. They will count with the presence of international prestigious scientific leaders in a wide different range of aspects related to the microbiome study, such as medicine, health sciences, computational sciences, mathematics, among others.
Further information: B·Debate
- Leave a comment
- All comments